Cargando…

Jaundice in a patient treated with Anakinra in a context of Covid-19

Detalles Bibliográficos
Autores principales:	Tarhini, H., Husain, M., Poey, N., Lariven, S., Lescure, F.-X., Yazdanpanah, Y., Gervais, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7526624/ https://www.ncbi.nlm.nih.gov/pubmed/33010355 http://dx.doi.org/10.1016/j.medmal.2020.09.011

Ejemplares similares

Pulmonary bacterial infections in adult patients hospitalized for COVID-19 in standard wards
por: Husain, M., et al.
Publicado: (2022)

First case of mild encephalopathy with reversible splenial lesion in SARS-CoV-2 infection
por: Chauffier, J., et al.
Publicado: (2021)

Anakinra: Jaundice: case report
Publicado: (2021)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report
por: Karadeniz, Hazan, et al.
Publicado: (2020)

Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Anakinra: a silver lining in COVID-19?
por: Gupta, Rahul
Publicado: (2020)

Severe Jaundice in a COVID-19 Patient–Virus or Drug?
por: Jothimani, Dinesh, et al.
Publicado: (2021)

Sociodemographic characteristics and transmission risk factors in patients hospitalized for COVID-19 before and during the lockdown in France
por: Rahi, Mayda, et al.
Publicado: (2021)

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020)

Accelerating clinical trial implementation in the context of the COVID-19 pandemic: author's response
por: Trøseid, Marius, et al.
Publicado: (2022)

Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patients
por: Piconi, Stefania, et al.
Publicado: (2023)

Contributions and challenges of community pharmacists during the COVID-19 pandemic: a qualitative study
por: Durand, Claire, et al.
Publicado: (2022)

Caractéristiques sociodémographiques et modes d’exposition chez les patients hospitalisés pour COVID-19 avant et pendant la période de confinement
por: Rahi, M., et al.
Publicado: (2020)

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection()
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

Neonatal adrenal hemorrhage and neonatal jaundice
por: Wiwanitkit, Viroj
Publicado: (2010)

Morgagni Hernia presenting as Obstructive Jaundice
por: Raj, Prince, et al.
Publicado: (2015)

COVID-19 vaccine, immune thrombotic thrombocytopenia, jaundice, hyperviscosity: concern on cases with underlying liver problem
por: Sookaromdee, Pathum, et al.
Publicado: (2021)

A Case of Congenital Leukemia with Nasal Hemorrhage and Jaundice
por: Matinzadeh, Zahra Khalili, et al.
Publicado: (2010)

Haly Abbas and the Early Description of Obstructive Jaundice
por: HEYDARI, Mojtaba, et al.
Publicado: (2014)

Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
por: Roy, Noémi B A, et al.
Publicado: (2020)

Pancreatobiliary and peripancreatobiliary tuberculosis: a rare cause of obstructive jaundice
por: Shen, Zhenbin, et al.
Publicado: (2013)

Co-infection et surinfection bactérienne chez les patients hospitalisés pour COVID-19: une étude rétrospective monocentrique
por: Husain, M., et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Maoujoud, Omar, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Valette, Xavier, et al.
Publicado: (2020)

Anakinra for patients with COVID-19
por: Martin-Silva, Nicolas, et al.
Publicado: (2020)

Effect of anakinra in COVID-19
por: Kooistra, Emma J, et al.
Publicado: (2020)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: comment
por: Yurttutan, Sadık, et al.
Publicado: (2021)

Anakinra after treatment with corticosteroids alone or with tocilizumab in patients with severe COVID‑19 pneumonia and moderate hyperinflammation. A retrospective cohort study: reply
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2021)

Early introduction of anakinra improves acute pericarditis and prevents tamponade in Staphylococcal sepsis
por: Sicignano, Ludovico Luca, et al.
Publicado: (2021)

Hepatic artery aneurysm: a rare case of obstructive jaundice with severe hemobilia
por: Peter, George, et al.
Publicado: (2014)

The Effects of Wet Cupping in the Management of Neonatal Jaundice: A Case Series Observation
por: Azizkhani, Mohammad, et al.
Publicado: (2021)

Arbaeen in the Context of the COVID-19 Pandemic
por: Hamdanieh, Lara, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Laine, Marc, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Adil Rashid, et al.
Publicado: (2020)

Anakinra for severe forms of COVID-19
por: Khan, Naim Akhtar
Publicado: (2020)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Refractory Sweet Syndrome Treated with Anakinra
por: Shahid, Zainab, et al.
Publicado: (2019)

Cerebral autoinflammatory disease treated with anakinra
por: Jang, Yoonhyuk, et al.
Publicado: (2018)

Myeloid Sarcoma of the Parotid Gland and Stomach Presenting with Obstructive Jaundice: A Rare Presentation
por: Thambi, Sugeeth M., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_t53fg4u966g7h5d8o23pl9j79e